| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |